Pharmaceutical Technology

MARCH 7, 2025

How to ensure safety and quality in pharmaceutical facilities when using HPAPIs in drug development. Read more here.

Containment 130

Containment Manufacturing Development Drugs 130

Drug Patent Watch

JANUARY 14, 2025

But how do companies develop these cost-effective alternatives? Generic drug manufacturers are taking a similar approach by developing multiple drugs simultaneously[1]. ”[2] This study not only addressed the ATA’s concerns but also highlighted the power of real-world evidence in generic drug development and regulation.

Generic Drugs 87

Generic Drugs Development Drugs Manufacturing 87

Pharmaceutical Technology

OCTOBER 19, 2023

AN2 Therapeutics has signed an agreement for advancing the development of a new boron-containing small molecule to treat Chagas disease.

Development 147

Development Containment 147

Camargo

NOVEMBER 11, 2020

Each month, Camargo’s “In the News” series highlights important changes and advancements in the regulatory and development space and explores how those changes could impact your program. Still, navigating such patent issues during drug development can be difficult, and Camargo can assist in finding a safe course. Ken Phelps.

Development 242

Development Bioequivalency Generic Drugs Production 242

Rethinking Clinical Trials

OCTOBER 2, 2023

The Patient-Centered Outcomes Core has developed a new tool kit to provide resources to support the capture of patient-reported outcome (PRO) measures in diverse study populations. The post October 2, 2023: Patient-Centered Outcomes Core Develops Tool Kit to Promote Health Equity in PROs appeared first on Rethinking Clinical Trials.

Development 182

Development Nurses Clinical Trials Clinical Trials 182

Pharma Times

FEBRUARY 12, 2024

The platform delivers digitalised patient data to improve clinical trials and development

Containment 150

Containment Trials Clinical Trials Clinical Trials 150

Camargo

OCTOBER 14, 2021

Each month, Camargo’s “In the News” series highlights important changes and advancements in the regulatory and development space and explores how those changes could impact your program. Continued development of the use of complex innovative trial designs. Continue development of the use of Real-World Evidence. Orientation.

Development 189

Development Packaging Packaging Generic Drugs 189

Camargo

NOVEMBER 15, 2021

Each month, Camargo’s “In the News” series highlights important changes and advancements in the regulatory and development space and explores how those changes could impact your program. The guidance also contains some useful information, despite the limitations described above. That potential has now been realized.

Development 187

Development Manufacturing Production Packaging 187

Camargo

NOVEMBER 29, 2021

The development of biological products (or biologics) represents a major advancement in modern medicine, enabling the treatment of patients with many illnesses where no other therapeutics were previously available. Essentially, a biologic is a product that is produced from living organisms or that contains components of living organisms.

Development 180

Development Protein Production Hormones 180

Pharmaceutical Technology

OCTOBER 6, 2022

from the US National Institutes of Health (NIH) unit National Institute of Allergy and Infectious Diseases (NIAID) to develop a prophylactic intranasal vaccine against Neisseria gonorrhoeae (NG). Leveraging its outer membrane vesicles (OMV) platform technology, Intravacc will develop the vaccine.

Vaccination 147

Vaccination Vaccine Development Bacterium 147

XTalks

JANUARY 30, 2025

In 2020, the US Food and Drug Administration (FDA) issued a Guidance for Industry recommending that sponsors include plans for developing age-appropriate formulations of drug products in instances where adult formulations may not be suitable for paediatric patients.

Manufacturing 52

Manufacturing Development Compliance Production 52

Pharmaceutical Technology

MAY 11, 2023

The vaccine, developed by BioNTech, led to half of the patients with pancreatic cancer in the Phase I trial remaining cancer-free 18 months later. In the study, 16 patients were treated with a vaccine called autogene cevumeran that contained a maximum of 20 neoantigens, alongside Roche’s anti-PD-L1 immunotherapy Tecentriq (atezolizumab).

RNA 345

RNA Vaccination Vaccine Trials 345

Pharmaceutical Technology

MAY 10, 2023

This marks a significant development in a tumultuous dispute between the pharmaceutical company and the US government. This research dates to the mid-2000s when CDC scientists developed the PrEP regimen, argued the government. While both Descovy and Truvada contain emtricitabine, they feature different forms of the antiviral tenofovir.

Drugs 264

Drugs FDA Approval Containment Licensing 264

Camargo

JANUARY 14, 2021

Each month, Camargo’s “In the News” series highlights important changes and advancements in the regulatory and development space and explores how those changes could impact your program. If you are developing a combination product, Camargo can help you design the fastest, most efficient path to approval. Co-Authors: Ken Phelps.

Development 148

Development Production FDA Approval Drugs 148

Camargo

DECEMBER 13, 2021

The development of biological products (or biologics) represents a major advancement in modern medicine, enabling the treatment of patients with many illnesses where no other therapeutics were previously available. Regulatory Considerations for Biologics. Section 351(a) is the traditional pathway for approving biologics under the PHS Act.

Development 161

Development Production Immune Response Licensing 161

Medical Xpress

MAY 16, 2023

A vegan diet does not affect maternal breastmilk concentrations of vitamin B2 and carnitine, nutrients essential for the developing infant. These are the results of an Amsterdam UMC study, presented today at the 55th Annual Meeting of the European Society for Pediatric Gastroenterology, Hepatology and Nutrition (ESPGHAN).

Containment 98

Containment Development 98

Pharmaceutical Technology

AUGUST 3, 2022

The potential to use these scientific breakthroughs to make a real difference to patients’ lives is what drives many highly skilled scientists to the world of drug development. This is where the process development stage, which directly follows the drug discovery and early formulation work, can make or break a drug’s success.

Development 130

Development Production Manufacturing Bioavailability 130

Pharmaceutical Technology

APRIL 14, 2023

Ghana’s Food and Drug Authority (FDA) has approved R21/Matrix-M malaria vaccine in children aged 5 to 36 months, marking the first regulatory clearance for the University of Oxford-developed vaccine in any country in the world. The WHO, which has already recommended GSK’s RTS,S/AS01 malaria vaccine , is yet to recommend Oxford’s R21 vaccine.

Vaccination 279

Vaccination Vaccine Manufacturing Containment 279

Camargo

APRIL 20, 2021

This trend progressively reduces the attractiveness of engaging in the early stages of oncology therapy development in the eyes of Big Pharma and opens the space for small pharma and biotech players. Become Fluent in the Drug Development “Languages.”. The language of accounting, to optimally allocate capital to maximize results.

Development 137

Development Genotoxicity Production Drugs 137

Camargo

JUNE 4, 2021

Each month, Camargo’s “In the News” series highlights important changes and advancements in the regulatory and development space and explores how those changes could impact your program. In the News: May 2021 Regulatory and Development Updates. In the News: April 2021 Regulatory and Development Updates.

Development 130

Development Production Drugs Marketing 130

Pfizer

AUGUST 22, 2022

Hospira Issues A Voluntary Nationwide Recall For One Lot of Propofol Injectable Emulsion (containing benzyl alcohol), Due To The Potential Presence of Visible Particulates. It is a sterile, nonpyrogenic emulsion containing 10 mg/mL of propofol suitable for intravenous administration supplied in a Single Patient Use Glass Fliptop Vial.

Containment 97

Containment Production Vaccination Vaccine 97

Pharma Times

MARCH 27, 2023

Company is developing a therapy containing an enzyme cloned from medical maggots

Containment 137

Containment Development 137

Camargo

DECEMBER 9, 2020

Camargo can help you to develop the right pricing and access strategy for your product; contact us for more information. A lesser-known provision also grants the same seven-year market exclusivity if the sponsor demonstrates that it does not expect to recover the development costs from selling the drug. Ken Phelps. Bill Stoltman, JD.

Development 140

Development Production Drugs FDA Approval 140

Bio Pharma Dive

MARCH 20, 2023

Speeding up the drug development process through a less optimized containment and delivery system may have been an option in the past, but both expectations and the competitive environment are changing.

Production 130

Production Containment Development Drugs 130

Pharmaceutical Technology

MAY 2, 2023

As a result, the EUAs of the original monovalent mRNA vaccines developed by Pfizer/BioNTech and Moderna for the prevention of Covid-19 have been revoked, meaning they are no longer authorised for use in the US. Novavax is currently developing a bivalent Omicron-specific vaccine with plans to commercialise the updated vaccine later this year.

Vaccination 52

Vaccination Vaccine RNA Development 52

Pharma Marketing Network

JULY 13, 2023

Your website is your online storefront, so it’s important to choose the best web development company to create it. In the pharmaceutical industry, where trust and credibility are essential, it’s especially important to choose a web development company that understands the specific needs of your business. Trust your gut.

Development 97

Development Regulation Compliance Containment 97

Pharmaceutical Technology

SEPTEMBER 15, 2022

Research by GlobalData (Contract Small Molecule API Manufacturing Industry by the Numbers – 2021 Edition) shows that containment facilities are in high demand as the use of cytotoxic drugs continues to grow. Adding to these factors is that oncology accounts for the majority of marketed, contained drugs. Containment challenges.

Containment 130

Containment Manufacturing Production Contract Manufacturing 130

Pharmaceutical Technology

JUNE 9, 2023

VEVYE, the development name of which is CyclASol, is a cyclosporine, solubilised solution in a new, water-free excipient. CyclASol is topical anti-inflammatory and immunomodulating ophthalmic drug solution containing 0.1%

FDA Approval 246

FDA Approval Bioavailability Containment Drugs 246

Pfizer

AUGUST 3, 2022

Pfizer to Discontinue Development Program for PF-07265803 for LMNA-Related Dilated Cardiomyopathy. Pfizer to Discontinue Development Program for PF-07265803 for LMNA-Related Dilated Cardiomyopathy. Based on these results, the Phase 3 trial and further development of PF-07265803 will be discontinued. deliesschef.

Development 101

Development Vaccination Vaccine Production 101

Medical Xpress

APRIL 6, 2023

In a recent study, researchers at Penn State found that broccoli contains certain molecules that bind to a receptor within mice and help to protect the lining of the small intestine, thereby inhibiting the development of disease. The findings lend support to the idea that broccoli truly is a "superfood."

Containment 145

Containment Research Development 145

Pharmaceutical Technology

AUGUST 5, 2022

The development of therapeutics for transmissible spongiform encephalopathies (TSEs) continues to be challenged by the complex nature of these diseases. According to GlobalData’s Pharma Intelligence Center, there are only six drugs in active development for CJD, of which only one has been in clinical trials.

Drugs 299

Drugs Protein Vaccination Vaccine 299

Pharmaceutical Technology

AUGUST 1, 2022

The mRNA-1273.222 vaccine containing the BA.4/5 4/5 Omicron strain is being developed in line with the latest recommendations from the Food and Drug Administration (FDA). Last month, the company announced the advancement of two bivalent candidates based on various population health security approaches in different countries.

Vaccination 289

Vaccination Vaccine Gene Therapy RNA 289

Medical Xpress

FEBRUARY 15, 2023

Human sweat contains chemical information including blood metabolites, ion concentrations, and nutrients. Monitoring this information using a wearable sensor can allow non-invasive (i.e., without blood sampling), real time health status tracking.

Containment 100

Containment Development 100

pharmaphorum

MAY 6, 2021

UK biotech Inspira Pharmaceuticals has emerged from stealth mode with a deal with Vectura to develop an inhaled therapy for COVID-19 that could be ready for human testing within 12 months. . ” The post New UK biotech Inspira uncloaks with deal to develop inhaled COVID therapy appeared first on.

Development 111

Development Research Containment Protein 111

XTalks

JUNE 10, 2021

Researchers at Massachusetts Institute of Technology (MIT) have designed the world’s first digital fabric fiber that contains digital devices which can sense, analyze and store health data, and use it to infer a person’s activity and state of health. The digital fibers can be sewn into clothing to help monitor bodily functions.

Research 111

Research Development Containment Engineer 111

Pharmaceutical Technology

SEPTEMBER 6, 2022

The download contains detailed information on the providers and their services and solutions, alongside contact details to aid your purchasing or hiring decision. Rise of pharma cold chain logistics companies. The post Leading pharmaceutical logistics and pharma supply chain companies appeared first on Pharmaceutical Technology.

Containment 147

Containment Pharmacy Life Science Production 147

XTalks

APRIL 25, 2024

Now we recognize that over the last ten years or so there have been major developments in pharmacotherapy for the management of different etiologies of heart failure,” says Dr. Nicholas Alp, MD, PhD, FACC, FRCP, Vice President of the Medical Department at Medpace. The Carillon device, developed by Cardiac Dimensions Inc.

Development 111

Development Trials Clinical Trials Clinical Trials 111